The global sweetener and food ingredients industry is set for significant consolidation after U.S.-based Ingredion Incorporated agreed to acquire UK-based Tate & Lyle in a deal valued at approximately £2.7 billion ($3.6 billion).
Under the agreement, Ingredion will pay up to 615 pence per share for Tate & Lyle, comprising 595 pence in cash along with dividend payments. The transaction values the British company at £2.7 billion, or approximately £3.7 billion including debt, Yahoo finance reported.
The acquisition follows several earlier approaches by Ingredion and comes at a time when Tate & Lyle has faced challenging market conditions. The company issued a profit warning last year and reported a 10 percent decline in first-half profits as weaker consumer demand and rising costs affected performance.
Tate & Lyle Chairman David Hearn said the merger would create a larger business with greater scale, enhanced innovation capabilities and stronger support for customers worldwide. He added that the board believes the offer provides shareholders with an attractive opportunity to realize value while ensuring a strong future for the company.
The deal represents another high-profile takeover of a British-listed company by an overseas buyer, continuing a trend that has seen several UK firms acquired or taken private in recent years.
Founded more than 165 years ago, Tate & Lyle has evolved from a traditional sugar producer into a global specialty ingredients company. The business sold its sugar division, including the famous Golden Syrup operations, in 2010 and has since focused on sweeteners, texturants and food ingredient solutions for the food and beverage industry.
The company further expanded its ingredients portfolio in 2024 through the acquisition of CP Kelco in a transaction valued at approximately £1.4 billion.
For Ingredion, the acquisition strengthens its position in the global ingredients market. The company employs more than 12,000 people worldwide and manufactures a wide range of sweeteners, starches, nutritional ingredients and biomaterials used in food, beverages, pharmaceuticals and industrial applications.
Industry analysts view the transaction as a strategic move that will create a larger and more diversified ingredients company with expanded research, development and innovation capabilities. The combined business is expected to benefit from growing global demand for specialty sweeteners, health-focused food ingredients and value-added nutrition products.
The takeover also highlights ongoing consolidation within the global food ingredients sector as companies seek greater scale, operational efficiencies and stronger product portfolios to navigate changing consumer preferences and increasingly competitive markets.
